New drug trial targets Tough-to-Treat uterine cancers
NCT ID NCT03668340
Summary
This study is testing an experimental drug called AZD1775 to see if it is safe and effective for women with a specific, hard-to-treat form of uterine cancer that has come back or persisted after prior treatment. The drug works by blocking a protein that helps cancer cells grow and divide. The goal is to see if the drug can shrink tumors and delay cancer progression.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UTERINE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02215, United States
Conditions
Explore the condition pages connected to this study.